This website has been developed by Novo Nordisk UK and contains product and prescribing information about Saxenda® (liraglutide), NovoRapid® (insulin aspart), and Norditropin® (somatropin) intended for UK healthcare professionals.
Reporting of side effects
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/↗ or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Novo Nordisk
Limited.
(Telephone Novo Nordisk Customer Care Centre 0800
0232573). Calls may be monitored for training purposes.